Clinical trial NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Official title: A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT)
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: PHASE3
Conditions: Primary Prevention of Atherosclerotic Cardiovascular Disease
Keywords: Inclisiran
PCSK9
primary prevention
cardiovascular disease
MACE
myocardial infarction
stroke
LDL-C
hyperlipidemia
hypercholesterolemia
dyslipidemia
cholesterol
Coronary Artery Disease (CAD)
Non-Obstructive Coronary Artery Disease (NOCAD)
Coronary Artery Calcium
Coronary artery stenosis
Coronary angiogram
Lead sponsor: Novartis
Sponsor class: INDUSTRY
First posted: 2023-02-22
Enrollment: 14013
Sex: ALL
Minimum age (years): 40
Maximum age (years): 79
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: CKJX839D12302 is a pivotal Phase III study designed to test the hypothesis that treatment with inclisiran sodium 300 milligram (mg) subcutaneous (s.c.) administered on Day 1, Day 90, and every 6 months thereafter in patients at high cardiovascular (CV) risk without a prior major atherosclerotic cardiovascular disease (ASCVD) event will significantly reduce the risk of 4-Point-Major Adverse Cardiovascular Events (4P-MACE) defined as a composite of CV death, non-fatal myocardial infarction (MI), non-fatal ischemic stroke, and urgent coronary revascularization, compared to placebo.

Detailed description: The purpose of this study is to evaluate inclisiran sodium 300 mg s.c. (equivalent to 284 mg inclisiran) compared to placebo on reducing the risk of 4P-MACE in adult patients at high risk for their first major adverse cardiovascular event.

Randomized participants will receive study medication (inclisiran or placebo), administered s.c. on Day 1, Day 90, then every 6 months thereafter. This is an event-driven study. Therefore, the study will continue until the required number of clinical events have occurred across both treatment arms, and all participants have a minimum of 3 years of follow-up during the double-blind treatment period.

Eligibility criteria: Inclusion Criteria:

* At an increased risk for a first MACE (i.e., no prior major ASCVD event), defined as any one of the following:

  1. Evidence of atherosclerotic coronary artery disease (CAD) on computer tomography (CT) or invasive coronary angiogram defined as a coronary artery stenosis ≥20% but \<50% in the left main coronary artery or stenosis ≥20% but \<70% in any other major epicardial coronary artery, or
  2. Coronary artery calcium (CAC) score obtained by CT-scan ≥100 Agatston units, or
  3. High 10-year ASCVD risk ≥20%, or
  4. Intermediate 10-year ASCVD risk 7.5% - \<20% with at least 2 risk-enhancing factors.
* LDL-C ≥70 mg/dL (≥1.81 mmol/L) but \<190 mg/dL (\<4.91 mmol/L) at the screening visit. If on a background lipid lowering therapy, the dose should be stable for at least 4 weeks prior to the screening visit and the participant should be willing to remain on this background therapy for the entire duration of the study.

Exclusion Criteria:

* History of major ASCVD event.
* History of, or planned, ischemia-driven revascularization in a coronary or extracoronary arterial bed prior to randomization
* Absence of coronary atherosclerosis on a CT angiogram or an invasive coronary angiogram in the 2 years prior to randomization
* Coronary artery calcium (CAC) score of 0 obtained in the 2 years prior to randomization
* Active liver disease or hepatic dysfunction
* Previous, current, or planned treatment with a monoclonal antibody (mAb) directed toward proprotein convertase subtilisin/kexin type 9 (PCSK9) (e.g., evolocumab, alirocumab)
* Pregnant or nursing (lactating) women
* Women of childbearing potential unless they are using effective methods of contraception while taking study treatment which includes for 6 months after last study drug administration

Other protocol-defined inclusion/exclusion criteria may apply.

Primary outcomes:
measure: Time to the first occurrence of 4P-MACE
timeFrame: Time to the first occurrence of 4P-MACE (up to approximately 75 months)
Secondary outcomes:
measure: Time to the first occurrence of 3P-MACE
timeFrame: Time to the first occurrence of 3P-MACE (up to approximately 75 months)
measure: Total number of first or repeated CV events (4P MACE)
timeFrame: up to 75 months
measure: Total number of first or repeated CV events (3P MACE)
timeFrame: up to 75 months
measure: Time to occurrence of Cardiovascular death
timeFrame: Time to Cardiovascular death (up to 75 months)
measure: Time to occurrence of death due to any reason
timeFrame: Time to all-cause mortality (up to 75 months)
Other outcomes:
Locations:
city: Birmingham
country: United States
facility: Central Alabama Research
state: Alabama
city: Birmingham
country: United States
facility: Ascension St Vincents
state: Alabama
city: Fairhope
country: United States
facility: Eastern Shore Research Institute
state: Alabama
city: Foley
country: United States
facility: G and L Research LLC
state: Alabama
city: Huntsville
country: United States
facility: Longwood Research
state: Alabama
city: Mobile
country: United States
facility: CB Flock Corporation
state: Alabama
city: Mobile
country: United States
facility: Mobile Heart Specialists
state: Alabama
city: Saraland
country: United States
facility: The Center for Clinical Trials
state: Alabama
city: Anchorage
country: United States
facility: Alaska Heart and Vascular
state: Alaska
city: Glendale
country: United States
facility: Synexus
state: Arizona
city: Glendale
country: United States
facility: Lenzmeier Family Practice
state: Arizona
city: Phoenix
country: United States
facility: Cognitive Clinical Trials LLC
state: Arizona
city: Sun City West
country: United States
facility: Clinical Research Inst of Arizona
state: Arizona
city: Tempe
country: United States
facility: Clinical Research Advantage Fiel Family and Sports Med, PC
state: Arizona
city: Tucson
country: United States
facility: Synexus Clinical Research US Inc
state: Arizona
city: Beverly Hills
country: United States
facility: Cardiovascular Res Found
state: California
city: Beverly Hills
country: United States
facility: National Heart Institute
state: California
city: Canoga Park
country: United States
facility: Hope Clinical Research
state: California
city: Los Angeles
country: United States
facility: Keck Medical Center USC
state: California
city: Los Angeles
country: United States
facility: Charles R Drew University of Medicine and Science
state: California
city: Newhall
country: United States
facility: C for Endo Diabetes and MD
state: California
city: Northridge
country: United States
facility: California Medical Research Associates Inc
state: California
city: Northridge
country: United States
facility: Valley Clinical Trials
state: California
city: Sacramento
country: United States
facility: Clinical Trials Research Sacramento
state: California
city: Sacramento
country: United States
facility: Cordova Clinical Research
state: California
city: San Diego
country: United States
facility: University of California San Diego
state: California
city: San Diego
country: United States
facility: Kaiser Permanente San Diego
state: California
city: San Diego
country: United States
facility: Acclaim Clinical Research
state: California
city: San Diego
country: United States
facility: San Diego Cardiac Center
state: California
city: Spring Valley
country: United States
facility: Encompass Clinical Research
state: California
city: Stanford
country: United States
facility: Stanford University Medical Center
state: California
city: Torrance
country: United States
facility: Uni of California at Los Angeles
state: California
city: Tustin
country: United States
facility: Tilda Research
state: California
city: Ventura
country: United States
facility: Cardiology Associates Medical Group
state: California
city: Vista
country: United States
facility: Blue Coast Research Center LLC
state: California
city: West Hills
country: United States
facility: Interv Cardiology Med Grp
state: California
city: Littleton
country: United States
facility: South Denver Cardiology Associates PC
state: Colorado
city: Stamford
country: United States
facility: Cardiology Ass of Fairfield County
state: Connecticut
city: Waterbury
country: United States
facility: Chase Medical Research LLC
state: Connecticut
city: Boca Raton
country: United States
facility: Excel Medical Clinical Trials LLC
state: Florida
city: Bradenton
country: United States
facility: Nova Clinical Research LLC
state: Florida
city: Clearwater
country: United States
facility: Bay Care Medical Group
state: Florida
city: Clearwater
country: United States
facility: Clearwater Cardiovascular and Interventional Consultants
state: Florida
city: Clearwater
country: United States
facility: Tampa Bay Medical Research
state: Florida
city: Daytona Beach
country: United States
facility: Cardiology Research Associates
state: Florida
city: DeLand
country: United States
facility: Hillcrest Medical Research
state: Florida
city: Delray Beach
country: United States
facility: Personal Physicians Care
state: Florida
city: Fleming Island
country: United States
facility: Fleming Island Ctr Clinical Res.
state: Florida
city: Fort Lauderdale
country: United States
facility: Proactive Clinical Research
state: Florida
city: Hialeah
country: United States
facility: Qway Research
state: Florida
city: Hialeah
country: United States
facility: Indago Research and Health Ctr Inc
state: Florida
city: Hialeah
country: United States
facility: Sister Life Research Inc
state: Florida
city: Hollywood
country: United States
facility: Center for Diabetes and Endocrine Care
state: Florida
city: Hollywood
country: United States
facility: South Florida Rsrch Solutions LLC
state: Florida
city: Hollywood
country: United States
facility: Zenith Clinical Research
state: Florida
city: Hollywood
country: United States
facility: Encore Medical Research
state: Florida
city: Jacksonville
country: United States
facility: University of Florida Health Science Center
state: Florida
city: Jacksonville
country: United States
facility: East Coast Institute for Research
state: Florida
city: Miami Gardens
country: United States
facility: Meridian International Research
state: Florida
city: Miami Lakes
country: United States
facility: Inpatient Research Clinical LLC
state: Florida
city: Miami Lakes
country: United States
facility: RM Medical Research Inc
state: Florida
city: Miami
country: United States
facility: Columbus Clinical Services LLC
state: Florida
city: Miami
country: United States
facility: Finlay Medical Research
state: Florida
city: Miami
country: United States
facility: Infinite Clinical Research
state: Florida
city: Miami
country: United States
facility: Springs Medical And Research
state: Florida
city: Miami
country: United States
facility: Regenerate Clinical Trial
state: Florida
city: Miami
country: United States
facility: L and C Professional Medical Institute
state: Florida
city: Miami
country: United States
facility: International Research Associates, LLC
state: Florida
city: Miami
country: United States
facility: A&A Research Group Inc
state: Florida
city: Miramar
country: United States
facility: Eminat LLC
state: Florida
city: Orlando
country: United States
facility: Advent Health Orlando
state: Florida
city: Palm Springs
country: United States
facility: CTMD Research
state: Florida
city: Pembroke Pines
country: United States
facility: DBC Research USA
state: Florida
city: Plant City
country: United States
facility: Fam Medical Specialists Of Fl Plc
state: Florida
city: Ponte Vedra
country: United States
facility: St Johns Center
state: Florida
city: Port Charlotte
country: United States
facility: Peace River Cardiovascular Center
state: Florida
city: Saint Augustine
country: United States
facility: East Coast Inst for Research LLC
state: Florida
city: Saint Petersburg
country: United States
facility: Advanced Medical Research Center
state: Florida
city: Sarasota
country: United States
facility: Cardiovascular Center Of Sarasota
state: Florida
city: Tampa
country: United States
facility: James A Haley Veterans Hospital
state: Florida
city: Tampa
country: United States
facility: BayCare Health System
state: Florida
city: Wellington
country: United States
facility: Cardiology Partners Clinical Research Institute
state: Florida
city: Canton
country: United States
facility: East Coast Research
state: Georgia
city: Fayetteville
country: United States
facility: Javara Research
state: Georgia
city: Tucker
country: United States
facility: Atlanta Heart Specialists LLC
state: Georgia
city: Honolulu
country: United States
facility: East West Research Institute
state: Hawaii
city: Sandpoint
country: United States
facility: Kootenai Heart Clinic-Sandpoint
state: Idaho
city: Arlington Heights
country: United States
facility: Northwest Heart Clinical Rsrch LLC
state: Illinois
city: Chicago
country: United States
facility: Chicago Clinical Research Inst
state: Illinois
city: Chicago
country: United States
facility: University of Illinois at Chicago
state: Illinois
city: Grandwood Park
country: United States
facility: Flourish Research
state: Illinois
city: Peoria
country: United States
facility: Cardiovascular Services
state: Illinois
city: Elkhart
country: United States
facility: Beacon Health System
state: Indiana
city: Indianapolis
country: United States
facility: Franciscan Health Services Research Center
state: Indiana
city: Valparaiso
country: United States
facility: Buynak Clinical Research PC
state: Indiana
city: Council Bluffs
country: United States
facility: West Broadway Clinic
state: Iowa
city: Hutchinson
country: United States
facility: Hutchinson Clinic
state: Kansas
city: Topeka
country: United States
facility: Cotton O Neil Clinical Res Center
state: Kansas
city: Wichita
country: United States
facility: Kansas Heart Hospital
state: Kansas
city: Bowling Green
country: United States
facility: Graves Gilbert Clinic
state: Kentucky
city: Lexington
country: United States
facility: The Research Group
state: Kentucky
city: Owensboro
country: United States
facility: Research Integrity LLC
state: Kentucky
city: Alexandria
country: United States
facility: Christus Health Central Lousia
state: Louisiana
city: Covington
country: United States
facility: Cardiovascular Associates Research
state: Louisiana
city: Covington
country: United States
facility: Louisiana Heart Center Research
state: Louisiana
city: Crowley
country: United States
facility: Avant Research Associates LLC
state: Louisiana
city: Mandeville
country: United States
facility: North Shore Heart and Vascular
state: Louisiana
city: Marrero
country: United States
facility: Bethesda Medical Clinic
state: Louisiana
city: Metairie
country: United States
facility: NOLA Care Clinical Research
state: Louisiana
city: Metairie
country: United States
facility: Omega Clinical Research
state: Louisiana
city: Natchitoches
country: United States
facility: Barnum Medical Research Inc
state: Louisiana
city: Opelousas
country: United States
facility: CV Ins of the South
state: Louisiana
city: Shreveport
country: United States
facility: Cardiovascular Solutions LLC
state: Louisiana
city: Slidell
country: United States
facility: Louisiana Heart Center Research
state: Louisiana
city: West Monroe
country: United States
facility: Monroe Research Llc
state: Louisiana
city: Zachary
country: United States
facility: Southern Clinical Research
state: Louisiana
city: Bangor
country: United States
facility: Northeast Cardiology Associates
state: Maine
city: Baltimore
country: United States
facility: Ascension Saint Agnes Heart Care
state: Maryland
city: Beltsville
country: United States
facility: Metropolitan Cardiovascular Consultants Llc
state: Maryland
city: Columbia
country: United States
facility: Johns Hopkins University
state: Maryland
city: Fort Washington
country: United States
facility: Anderson Medical Research
state: Maryland
city: Lanham
country: United States
facility: Capitol Cardiology Associates
state: Maryland
city: Boston
country: United States
facility: MGH
state: Massachusetts
city: Worcester
country: United States
facility: Umass Memorial Medical Center
state: Massachusetts
city: Detroit
country: United States
facility: Henry Ford Hospital
state: Michigan
city: Flint
country: United States
facility: AA Medical Research Center
state: Michigan
city: Midland
country: United States
facility: MyMichigan Medical Center Midland
state: Michigan
city: Saginaw
country: United States
facility: Central University Of Michigan
state: Michigan
city: Troy
country: United States
facility: Troy Internal Medicine Research
state: Michigan
city: Ypsilanti
country: United States
facility: Trinity Health Michigan Heart
state: Michigan
city: Duluth
country: United States
facility: Essentia Health Duluth Clinic
state: Minnesota
city: Minneapolis
country: United States
facility: Abbott Northwestern Hospital
state: Minnesota
city: Richfield
country: United States
facility: Synexus Clinical Research US Inc
state: Minnesota
city: Saint Louis Park
country: United States
facility: Park Nicollet Institute
state: Minnesota
city: Saint Paul
country: United States
facility: Fairview Health Services
state: Minnesota
city: Jackson
country: United States
facility: Elite Clinical Research LLC
state: Mississippi
city: Jackson
country: United States
facility: Jackson Heart Clinic
state: Mississippi
city: Jackson
country: United States
facility: VAMC Research-G V Sonny Montgomery Clinic
state: Mississippi
city: Port Gibson
country: United States
facility: David M Headley Clinic
state: Mississippi
city: Tupelo
country: United States
facility: Cardiology Associates of North MS
state: Mississippi
city: Kansas City
country: United States
facility: Kansas City VA Medical Center
state: Missouri
city: Saint Louis
country: United States
facility: Barnes Jewish Hosp-Washington Univ
state: Missouri
city: Saint Louis
country: United States
facility: St Louis V A Medical Center
state: Missouri
city: Saint Louis
country: United States
facility: St Louis Heart and Vascular
state: Missouri
city: Saint Louis
country: United States
facility: Synexus Clinical Research US Inc
state: Missouri
city: Saint Peters
country: United States
facility: StudyMetrix Research
state: Missouri
city: Butte
country: United States
facility: Mercury Street Medical
state: Montana
city: Lincoln
country: United States
facility: Nebraska Heart Institute
state: Nebraska
city: Lincoln
country: United States
facility: Lincoln Internal Medicine Associates
state: Nebraska
city: Omaha
country: United States
facility: VA Medical Center - NWI, Endocrine Studies (R151)
state: Nebraska
city: Henderson
country: United States
facility: Las Vegas Endocrinology
state: Nevada
city: Las Vegas
country: United States
facility: AB Clinical Trials
state: Nevada
city: Las Vegas
country: United States
facility: Clinical Research of South Nevada
state: Nevada
city: Bridgewater
country: United States
facility: Advanced Heart Care, LLC
state: New Jersey
city: Elmer
country: United States
facility: Cardiovas Assoc of Delaware Valley
state: New Jersey
city: Hackensack
country: United States
facility: Hackensack University Medical Center
state: New Jersey
city: Linden
country: United States
facility: New Jersey Heart
state: New Jersey
city: Albany
country: United States
facility: Albany Medical College
state: New York
city: Albany
country: United States
facility: Capital Cardiology Associates
state: New York
city: Flushing
country: United States
facility: New York Presbyterian Queens
state: New York
city: Kew Gardens
country: United States
facility: IMA Medical Research PC
state: New York
city: New Windsor
country: United States
facility: Mid Hudson Medical Research PLLC
state: New York
city: Poughkeepsie
country: United States
facility: Hudson Valley Urology
state: New York
city: Rochester
country: United States
facility: Rochester Clinical Research
state: New York
city: Smithtown
country: United States
facility: Endocrine Associates of Long Island P C
state: New York
city: Valhalla
country: United States
facility: Westchester Medical Center
state: New York
city: Westfield
country: United States
facility: Great Lakes Medical Research
state: New York
city: Cary
country: United States
facility: Cary Research Group
state: North Carolina
city: Greensboro
country: United States
facility: Moses Cone Hospital
state: North Carolina
city: Greensboro
country: United States
facility: Medication Management LLC
state: North Carolina
city: Greenville
country: United States
facility: Physicians East Endocrinology
state: North Carolina
city: Mount Airy
country: United States
facility: IMA Research
state: North Carolina
city: Raleigh
country: United States
facility: Multispecialty Research Ass Of NC
state: North Carolina
city: Statesville
country: United States
facility: Accellacare
state: North Carolina
city: Wilmington
country: United States
facility: Adv Imaging Prev and Clin Research
state: North Carolina
city: Winston-Salem
country: United States
facility: Wake Forest University Baptist Medical Center
state: North Carolina
city: Fargo
country: United States
facility: Lillestol Research LLC
state: North Dakota
city: Grand Forks
country: United States
facility: Altru Health Research Dept.
state: North Dakota
city: Canton
country: United States
facility: Aultman Hospital
state: Ohio
city: Cincinnati
country: United States
facility: Synexus Clinical Research US Inc
state: Ohio
city: Cleveland
country: United States
facility: Cleveland Clinic Foundation
state: Ohio
city: Columbus
country: United States
facility: Synexus Clinical Research
state: Ohio
city: Dayton
country: United States
facility: Primed Clinical Research
state: Ohio
city: Dayton
country: United States
facility: Providence Medical Group
state: Ohio
city: Lima
country: United States
facility: NexGen Research
state: Ohio
city: Marion
country: United States
facility: Rama Research LLC
state: Ohio
city: Springfield
country: United States
facility: Heart House Research Foundation
state: Ohio
city: Oklahoma City
country: United States
facility: Lynn Health Science Institute
state: Oklahoma
city: Oklahoma City
country: United States
facility: Hightower Clinical Research
state: Oklahoma
city: Oklahoma City
country: United States
facility: South Oklahoma Heart Research LLC
state: Oklahoma
city: Hatboro
country: United States
facility: CCT Hatboro Medical Associates
state: Pennsylvania
city: Newport
country: United States
facility: Capital Area Research LLC
state: Pennsylvania
city: Pittsburgh
country: United States
facility: Allegheny General Hospital
state: Pennsylvania
city: Smithfield
country: United States
facility: Frontier Clinical Research LLC
state: Pennsylvania
city: Warwick
country: United States
facility: Care Access
state: Rhode Island
city: Anderson
country: United States
facility: Synexus Clinical Research US Inc
state: South Carolina
city: Columbia
country: United States
facility: Columbia VA Health Care System
state: South Carolina
city: Greenville
country: United States
facility: Bon Secours Medical Group
state: South Carolina
city: Greer
country: United States
facility: Mountain View Clincal Research Inc
state: South Carolina
city: Ladson
country: United States
facility: Trident Cardiology
state: South Carolina
city: Little River
country: United States
facility: Main Street Physicians Care
state: South Carolina
city: Rapid City
country: United States
facility: Care Access Rapid City
state: South Dakota
city: Rapid City
country: United States
facility: Monument Health Clinical Research
state: South Dakota
city: Greenville
country: United States
facility: Wellmont CVA Heart Institute
state: Tennessee
city: Jackson
country: United States
facility: Apex Cardiology Research Associates of Jackson
state: Tennessee
city: Kingsport
country: United States
facility: Holston Medical Group
state: Tennessee
city: Knoxville
country: United States
facility: New Phase Research And Development
state: Tennessee
city: Knoxville
country: United States
facility: Accellacare
state: Tennessee
city: Powell
country: United States
facility: Cardiovascular Res of Knoxville LLC
state: Tennessee
city: Tullahoma
country: United States
facility: Tennessee Center For Clinical Trials
state: Tennessee
city: Amarillo
country: United States
facility: Pharma Tex Research
state: Texas
city: Amarillo
country: United States
facility: Amarillo Heart Clin Rsh Inst
state: Texas
city: Bedford
country: United States
facility: North Hills Medical Research Inc
state: Texas
city: Cypress
country: United States
facility: Clinical Research Solution
state: Texas
city: Dallas
country: United States
facility: VA North Texas Health Care System
state: Texas
city: Dallas
country: United States
facility: Zenos Clinical Research
state: Texas
city: Dallas
country: United States
facility: SW Family Medicine Associates
state: Texas
city: Edinburg
country: United States
facility: Doctors Hospital at Renaissance
state: Texas
city: El Paso
country: United States
facility: David Turbay MD PLLC
state: Texas
city: Fort Worth
country: United States
facility: Texas Health Physicians Group
state: Texas
city: Houston
country: United States
facility: East Texas Cardiology PA
state: Texas
city: Houston
country: United States
facility: Primecare Medical Group
state: Texas
city: Houston
country: United States
facility: Northwest Houston Cardiology PA
state: Texas
city: Houston
country: United States
facility: MedCare Pharma LLC
state: Texas
city: Houston
country: United States
facility: Biopharma Informatic LLC
state: Texas
city: Kingwood
country: United States
facility: Texas Cardiology Assocs Of Houston
state: Texas
city: Lewisville
country: United States
facility: Epic Clinical Research
state: Texas
city: Livingston
country: United States
facility: East Texas Research Associates Inc.
state: Texas
city: Pflugerville
country: United States
facility: Discovery Clinical Trials
state: Texas
city: Red Oak
country: United States
facility: Epic Medical Research
state: Texas
city: San Antonio
country: United States
facility: Northeast Clinical Research of San Antonio LLC
state: Texas
city: Shavano Park
country: United States
facility: Consano Clinical Research LLC
state: Texas
city: Stephenville
country: United States
facility: Javara Research
state: Texas
city: Sugar Land
country: United States
facility: NRG Wellness Center
state: Texas
city: Tomball
country: United States
facility: Northwest Houston Clinical Research PLLC
state: Texas
city: Weslaco
country: United States
facility: Comprehensive Center
state: Texas
city: Murray
country: United States
facility: Intermountain Medical Center
state: Utah
city: Murray
country: United States
facility: Synexus Clinical Research US Inc
state: Utah
city: Sandy
country: United States
facility: Diabetes And Endocrine Specialists
state: Utah
city: Burke
country: United States
facility: Burke Internal Medicine and Research
state: Virginia
city: Falls Church
country: United States
facility: Virginia Heart
state: Virginia
city: Hopewell
country: United States
facility: Heart Care Associates P C
state: Virginia
city: Manassas
country: United States
facility: Carient Heart and Vascular
state: Virginia
city: Manassas
country: United States
facility: Manassas Clinical Research Center
state: Virginia
city: Richmond
country: United States
facility: Virginia Commonwealth University
state: Virginia
city: Roanoke
country: United States
facility: Roanoke Heart Institute
state: Virginia
city: Suffolk
country: United States
facility: Centricity Research Suffolk Fam Med
state: Virginia
city: Puyallup
country: United States
facility: MultiCare Ins Research Innovation
state: Washington
city: Tacoma
country: United States
facility: Universal Research Group LLC
state: Washington
city: Wenatchee
country: United States
facility: Confluence Health Hospital
state: Washington
city: Morgantown
country: United States
facility: West Virginia University Hospital
state: West Virginia
city: Milwaukee
country: United States
facility: Midwest Endocrinology Associates
state: Wisconsin
city: Wausau
country: United States
facility: Cardiovascular Research and Education Foundation, Inc
state: Wisconsin
city: Caba
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Caba
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Caba
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Caba
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Caba
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Caba
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Caba
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Caba
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Ciudad Autonoma de Bs As
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Ciudad Autonoma de Bs As
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Lanus
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Mar del Plata
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Ramos Mejia
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: San Martin
country: Argentina
facility: Novartis Investigative Site
state: Buenos Aires
city: Concepcion del Uruguay
country: Argentina
facility: Novartis Investigative Site
state: Entre Ríos
city: Ciudad de Formosa
country: Argentina
facility: Novartis Investigative Site
state: Formosa
city: Ciudad de Salta
country: Argentina
facility: Novartis Investigative Site
state: Provincia De Salta
city: Santa Fe
country: Argentina
facility: Novartis Investigative Site
state: Rosario
city: Tucuman
country: Argentina
facility: Novartis Investigative Site
state: San Miguel De Tucuman
city: Grandero Baigorria
country: Argentina
facility: Novartis Investigative Site
state: Santa Fe
city: Rosario
country: Argentina
facility: Novartis Investigative Site
state: Santa Fe
city: Rosario
country: Argentina
facility: Novartis Investigative Site
state: Santa Fe
city: San Miguel de Tucuman
country: Argentina
facility: Novartis Investigative Site
state: Tucuman
city: San Miguel Del Tucuman
country: Argentina
facility: Novartis Investigative Site
state: Tucuman
city: Buenos Aires
country: Argentina
facility: Novartis Investigative Site
city: Buenos Aires
country: Argentina
facility: Novartis Investigative Site
city: Buenos Aires
country: Argentina
facility: Novartis Investigative Site
city: Caba
country: Argentina
facility: Novartis Investigative Site
city: Capital Federal
country: Argentina
facility: Novartis Investigative Site
city: Ciudad de Buenos Aires
country: Argentina
facility: Novartis Investigative Site
city: Cordoba
country: Argentina
facility: Novartis Investigative Site
city: Cordoba
country: Argentina
facility: Novartis Investigative Site
city: Cordoba
country: Argentina
facility: Novartis Investigative Site
city: Cordoba
country: Argentina
facility: Novartis Investigative Site
city: Cordoba
country: Argentina
facility: Novartis Investigative Site
city: Cordoba
country: Argentina
facility: Novartis Investigative Site
city: Cordoba
country: Argentina
facility: Novartis Investigative Site
city: Cordoba
country: Argentina
facility: Novartis Investigative Site
city: Corrientes
country: Argentina
facility: Novartis Investigative Site
city: Mendoza
country: Argentina
facility: Novartis Investigative Site
city: Parana
country: Argentina
facility: Novartis Investigative Site
city: San Luis
country: Argentina
facility: Novartis Investigative Site
city: Santa Fe
country: Argentina
facility: Novartis Investigative Site
city: Santa Fe
country: Argentina
facility: Novartis Investigative Site
city: Canberra
country: Australia
facility: Novartis Investigative Site
state: Australian Capital Territory
city: Camperdown
country: Australia
facility: Novartis Investigative Site
state: New South Wales
city: Concord
country: Australia
facility: Novartis Investigative Site
state: New South Wales
city: Auchenflower
country: Australia
facility: Novartis Investigative Site
state: Queensland
city: Sippy Downs
country: Australia
facility: Novartis Investigative Site
state: Queensland
city: Woolloongabba
country: Australia
facility: Novartis Investigative Site
state: Queensland
city: Adelaide
country: Australia
facility: Novartis Investigative Site
state: South Australia
city: Leabrook
country: Australia
facility: Novartis Investigative Site
state: South Australia
city: Hobart
country: Australia
facility: Novartis Investigative Site
state: Tasmania
city: Clayton
country: Australia
facility: Novartis Investigative Site
state: Victoria
city: Heidelberg
country: Australia
facility: Novartis Investigative Site
state: Victoria
city: Malvern East
country: Australia
facility: Novartis Investigative Site
state: Victoria
city: Joondalup
country: Australia
facility: Novartis Investigative Site
state: Western Australia
city: Braunau
country: Austria
facility: Novartis Investigative Site
city: Graz
country: Austria
facility: Novartis Investigative Site
city: Linz
country: Austria
facility: Novartis Investigative Site
city: Wien
country: Austria
facility: Novartis Investigative Site
city: Aalst
country: Belgium
facility: Novartis Investigative Site
city: Dendermonde
country: Belgium
facility: Novartis Investigative Site
city: Genk
country: Belgium
facility: Novartis Investigative Site
city: Hasselt
country: Belgium
facility: Novartis Investigative Site
city: Mechelen
country: Belgium
facility: Novartis Investigative Site
city: Maceio
country: Brazil
facility: Novartis Investigative Site
state: AL
city: Salvador
country: Brazil
facility: Novartis Investigative Site
state: BA
city: Salvador
country: Brazil
facility: Novartis Investigative Site
state: BA
city: Brasilia
country: Brazil
facility: Novartis Investigative Site
state: DF
city: Brasilia
country: Brazil
facility: Novartis Investigative Site
state: DF
city: Brasilia
country: Brazil
facility: Novartis Investigative Site
state: Distrito Federal
city: Vitoria
country: Brazil
facility: Novartis Investigative Site
state: ES
city: Belo Horizonte
country: Brazil
facility: Novartis Investigative Site
state: MG
city: Belo Horizonte
country: Brazil
facility: Novartis Investigative Site
state: MG
city: Uberlandia
country: Brazil
facility: Novartis Investigative Site
state: Minas Gerais
city: Curitiba
country: Brazil
facility: Novartis Investigative Site
state: Parana
city: Curitiba
country: Brazil
facility: Novartis Investigative Site
state: PR
city: Canoas
country: Brazil
facility: Novartis Investigative Site
state: RS
city: Pelotas
country: Brazil
facility: Novartis Investigative Site
state: RS
city: Porto Alegre
country: Brazil
facility: Novartis Investigative Site
state: RS
city: Porto Alegre
country: Brazil
facility: Novartis Investigative Site
state: RS
city: Porto Alegre
country: Brazil
facility: Novartis Investigative Site
state: RS
city: Blumenau
country: Brazil
facility: Novartis Investigative Site
state: Santa Catarina
city: Santo Andre
country: Brazil
facility: Novartis Investigative Site
state: Sao Paulo
city: Aracaju
country: Brazil
facility: Novartis Investigative Site
state: SE
city: Campinas
country: Brazil
facility: Novartis Investigative Site
state: SP
city: Ribeirao Preto
country: Brazil
facility: Novartis Investigative Site
state: SP
city: Sao Jose do Rio Preto
country: Brazil
facility: Novartis Investigative Site
state: SP
city: Sao Jose dos Campos
country: Brazil
facility: Novartis Investigative Site
state: SP
city: Sao Paulo
country: Brazil
facility: Novartis Investigative Site
state: SP
city: Sao Paulo
country: Brazil
facility: Novartis Investigative Site
state: SP
city: Sao Paulo
country: Brazil
facility: Novartis Investigative Site
state: SP
city: Sao Paulo
country: Brazil
facility: Novartis Investigative Site
state: SP
city: Votuporanga
country: Brazil
facility: Novartis Investigative Site
state: SP
city: Campinas
country: Brazil
facility: Novartis Investigative Site
city: Rio de Janeiro
country: Brazil
facility: Novartis Investigative Site
city: Rio de Janeiro
country: Brazil
facility: Novartis Investigative Site
city: Blagoevgrad
country: Bulgaria
facility: Novartis Investigative Site
city: Burgas
country: Bulgaria
facility: Novartis Investigative Site
city: Gabrovo
country: Bulgaria
facility: Novartis Investigative Site
city: Kyustendil
country: Bulgaria
facility: Novartis Investigative Site
city: Pernik
country: Bulgaria
facility: Novartis Investigative Site
city: Pleven
country: Bulgaria
facility: Novartis Investigative Site
city: Plovdiv
country: Bulgaria
facility: Novartis Investigative Site
city: Sandanski
country: Bulgaria
facility: Novartis Investigative Site
city: Sofia
country: Bulgaria
facility: Novartis Investigative Site
city: Sofia
country: Bulgaria
facility: Novartis Investigative Site
city: Sofia
country: Bulgaria
facility: Novartis Investigative Site
city: Sofia
country: Bulgaria
facility: Novartis Investigative Site
city: Sofia
country: Bulgaria
facility: Novartis Investigative Site
city: Sofia
country: Bulgaria
facility: Novartis Investigative Site
city: Stara Zagora
country: Bulgaria
facility: Novartis Investigative Site
city: Varna
country: Bulgaria
facility: Novartis Investigative Site
city: Veliko Tarnovo
country: Bulgaria
facility: Novartis Investigative Site
city: Calgary
country: Canada
facility: Novartis Investigative Site
state: Alberta
city: Edmonton
country: Canada
facility: Novartis Investigative Site
state: Alberta
city: Red Deer
country: Canada
facility: Novartis Investigative Site
state: Alberta
city: Kelowna
country: Canada
facility: Novartis Investigative Site
state: British Columbia
city: Vancouver
country: Canada
facility: Novartis Investigative Site
state: British Columbia
city: Moncton
country: Canada
facility: Novartis Investigative Site
state: New Brunswick
city: Halifax
country: Canada
facility: Novartis Investigative Site
state: Nova Scotia
city: New Minas
country: Canada
facility: Novartis Investigative Site
state: Nova Scotia
city: Barrie
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Brampton
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Etobicoke
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Guelph
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Hamilton
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: London
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Napean
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Newmarket
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: North York
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Oshawa
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Scarborough
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Thornhill
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Toronto
country: Canada
facility: Novartis Investigative Site
state: Ontario
city: Levis
country: Canada
facility: Novartis Investigative Site
state: Quebec
city: Mirabel
country: Canada
facility: Novartis Investigative Site
state: Quebec
city: Montreal
country: Canada
facility: Novartis Investigative Site
state: Quebec
city: Sainte Foy
country: Canada
facility: Novartis Investigative Site
state: Quebec
city: Terrebonne
country: Canada
facility: Novartis Investigative Site
state: Quebec
city: Trois Rivieres
country: Canada
facility: Novartis Investigative Site
state: Quebec
city: Victoriaville
country: Canada
facility: Novartis Investigative Site
state: Quebec
city: Quebec
country: Canada
facility: Novartis Investigative Site
city: Guangzhou City
country: China
facility: Novartis Investigative Site
state: Guangdong
city: Nanning
country: China
facility: Novartis Investigative Site
state: Guangxi
city: Cangzhou
country: China
facility: Novartis Investigative Site
state: Hebei
city: Tangshan
country: China
facility: Novartis Investigative Site
state: Hebei
city: Xingtai
country: China
facility: Novartis Investigative Site
state: Hebei
city: Daqing
country: China
facility: Novartis Investigative Site
state: Heilongjiang
city: Harbin
country: China
facility: Novartis Investigative Site
state: Heilongjiang
city: Harbin
country: China
facility: Novartis Investigative Site
state: Heilongjiang
city: Luoyang
country: China
facility: Novartis Investigative Site
state: Henan
city: Pingdingshan
country: China
facility: Novartis Investigative Site
state: Henan
city: Zhengzhou
country: China
facility: Novartis Investigative Site
state: Henan
city: Huangshi
country: China
facility: Novartis Investigative Site
state: Hubei
city: Wuhan
country: China
facility: Novartis Investigative Site
state: Hubei
city: Changsha
country: China
facility: Novartis Investigative Site
state: Hunan
city: Changsha
country: China
facility: Novartis Investigative Site
state: Hunan
city: Hohhot
country: China
facility: Novartis Investigative Site
state: Inner Mongolia
city: Changzhou
country: China
facility: Novartis Investigative Site
state: Jiangsu
city: Xuzhou
country: China
facility: Novartis Investigative Site
state: Jiangsu
city: Nanchang
country: China
facility: Novartis Investigative Site
state: Jiangxi
city: Tonghua
country: China
facility: Novartis Investigative Site
state: Jilin
city: Dalian
country: China
facility: Novartis Investigative Site
state: Liaoning
city: Jinzhou
country: China
facility: Novartis Investigative Site
state: Liaoning
city: Shenyang
country: China
facility: Novartis Investigative Site
state: Liaoning
city: Yinchuan
country: China
facility: Novartis Investigative Site
state: Ningxia
city: Xianyang
country: China
facility: Novartis Investigative Site
state: Shaanxi
city: Jinan
country: China
facility: Novartis Investigative Site
state: Shandong
city: Jining
country: China
facility: Novartis Investigative Site
state: Shandong
city: Qingdao
country: China
facility: Novartis Investigative Site
state: Shandong
city: Zibo
country: China
facility: Novartis Investigative Site
state: Shandong
city: Xian
country: China
facility: Novartis Investigative Site
state: Shanxi
city: Tianjin
country: China
facility: Novartis Investigative Site
state: Tianjin
city: Hangzhou
country: China
facility: Novartis Investigative Site
state: Zhejiang
city: Hangzhou
country: China
facility: Novartis Investigative Site
state: Zhejiang
city: Lishui City
country: China
facility: Novartis Investigative Site
state: Zhejiang
city: Wenzhou
country: China
facility: Novartis Investigative Site
state: Zhejiang
city: Beijing
country: China
facility: Novartis Investigative Site
city: Beijing
country: China
facility: Novartis Investigative Site
city: Guang Zhou
country: China
facility: Novartis Investigative Site
city: Jining
country: China
facility: Novartis Investigative Site
city: Shanghai
country: China
facility: Novartis Investigative Site
city: Shijiazhuang
country: China
facility: Novartis Investigative Site
city: Tianjin
country: China
facility: Novartis Investigative Site
city: Medellin
country: Colombia
facility: Novartis Investigative Site
state: Antioquia
city: Medellin
country: Colombia
facility: Novartis Investigative Site
state: Antioquia
city: Barranquilla
country: Colombia
facility: Novartis Investigative Site
state: Atlantico
city: Barranquilla
country: Colombia
facility: Novartis Investigative Site
state: Atlantico
city: Chia
country: Colombia
facility: Novartis Investigative Site
state: Cundinamarca
city: Bucaramanga
country: Colombia
facility: Novartis Investigative Site
state: Santander
city: Floridablanca
country: Colombia
facility: Novartis Investigative Site
state: Santander
city: Ibague
country: Colombia
facility: Novartis Investigative Site
state: Tolima
city: Cali
country: Colombia
facility: Novartis Investigative Site
state: Valle Del Cauca
city: Barranquilla
country: Colombia
facility: Novartis Investigative Site
city: Bogota
country: Colombia
facility: Novartis Investigative Site
city: Cali
country: Colombia
facility: Novartis Investigative Site
city: Manizales
country: Colombia
facility: Novartis Investigative Site
city: Medellin
country: Colombia
facility: Novartis Investigative Site
city: Medellin
country: Colombia
facility: Novartis Investigative Site
city: Medellin
country: Colombia
facility: Novartis Investigative Site
city: San Gil
country: Colombia
facility: Novartis Investigative Site
city: Karlovac
country: Croatia
facility: Novartis Investigative Site
state: Karlovacka Zupanija
city: Osijek
country: Croatia
facility: Novartis Investigative Site
state: Osijek Baranja
city: Rijeka
country: Croatia
facility: Novartis Investigative Site
state: Primorsko Goranska Zupanija
city: Krapinske toplice
country: Croatia
facility: Novartis Investigative Site
city: Krapinske Toplice
country: Croatia
facility: Novartis Investigative Site
city: Opatija
country: Croatia
facility: Novartis Investigative Site
city: Osijek
country: Croatia
facility: Novartis Investigative Site
city: Pula
country: Croatia
facility: Novartis Investigative Site
city: Rijeka
country: Croatia
facility: Novartis Investigative Site
city: Slavonski Brod
country: Croatia
facility: Novartis Investigative Site
city: Varazdin
country: Croatia
facility: Novartis Investigative Site
city: Vinkovci
country: Croatia
facility: Novartis Investigative Site
city: Zagreb
country: Croatia
facility: Novartis Investigative Site
city: Brandys nad Labem
country: Czechia
facility: Novartis Investigative Site
state: Czech Republic
city: Brno
country: Czechia
facility: Novartis Investigative Site
state: Czech Republic
city: Cesky Krumlov
country: Czechia
facility: Novartis Investigative Site
state: Czech Republic
city: Louny
country: Czechia
facility: Novartis Investigative Site
state: Czech Republic
city: Ostrava
country: Czechia
facility: Novartis Investigative Site
state: Czech Republic
city: Pardubice
country: Czechia
facility: Novartis Investigative Site
state: Czech Republic
city: Usti nad Labem
country: Czechia
facility: Novartis Investigative Site
state: Czech Republic
city: Znojmo
country: Czechia
facility: Novartis Investigative Site
state: Czech Republic
city: Ostrava
country: Czechia
facility: Novartis Investigative Site
state: CZE
city: Trutnov
country: Czechia
facility: Novartis Investigative Site
state: CZE
city: Prerov
country: Czechia
facility: Novartis Investigative Site
state: Olomoucky Kraj
city: Chlumec nad Cidlinou
country: Czechia
facility: Novartis Investigative Site
city: Hlucin
country: Czechia
facility: Novartis Investigative Site
city: Hodonin
country: Czechia
facility: Novartis Investigative Site
city: JIhlava
country: Czechia
facility: Novartis Investigative Site
city: Kolin
country: Czechia
facility: Novartis Investigative Site
city: Liberec
country: Czechia
facility: Novartis Investigative Site
city: Marianske lazne
country: Czechia
facility: Novartis Investigative Site
city: Nachod
country: Czechia
facility: Novartis Investigative Site
city: Olomouc
country: Czechia
facility: Novartis Investigative Site
city: Ostrava
country: Czechia
facility: Novartis Investigative Site
city: Ostrava
country: Czechia
facility: Novartis Investigative Site
city: Plzen
country: Czechia
facility: Novartis Investigative Site
city: Prague 5
country: Czechia
facility: Novartis Investigative Site
city: Praha 10
country: Czechia
facility: Novartis Investigative Site
city: Praha 11
country: Czechia
facility: Novartis Investigative Site
city: Praha
country: Czechia
facility: Novartis Investigative Site
city: Praha
country: Czechia
facility: Novartis Investigative Site
city: Uherske Hradiste
country: Czechia
facility: Novartis Investigative Site
city: Usti nad Labem
country: Czechia
facility: Novartis Investigative Site
city: Zlin
country: Czechia
facility: Novartis Investigative Site
city: Aarhus N
country: Denmark
facility: Novartis Investigative Site
city: Copenhagen S
country: Denmark
facility: Novartis Investigative Site
city: Esbjerg
country: Denmark
facility: Novartis Investigative Site
city: Gandrup
country: Denmark
facility: Novartis Investigative Site
city: Herlev
country: Denmark
facility: Novartis Investigative Site
city: Herning
country: Denmark
facility: Novartis Investigative Site
city: Kobenhavn N V
country: Denmark
facility: Novartis Investigative Site
city: Roskilde
country: Denmark
facility: Novartis Investigative Site
city: Svendborg
country: Denmark
facility: Novartis Investigative Site
city: Vejle
country: Denmark
facility: Novartis Investigative Site
city: Parnu
country: Estonia
facility: Novartis Investigative Site
city: Tallinn
country: Estonia
facility: Novartis Investigative Site
city: Tallinn
country: Estonia
facility: Novartis Investigative Site
city: Tallinn
country: Estonia
facility: Novartis Investigative Site
city: Tallinn
country: Estonia
facility: Novartis Investigative Site
city: Tartu
country: Estonia
facility: Novartis Investigative Site
city: Tartu
country: Estonia
facility: Novartis Investigative Site
city: Avignon
country: France
facility: Novartis Investigative Site
city: Besancon Cedex
country: France
facility: Novartis Investigative Site
city: Beziers Cedex
country: France
facility: Novartis Investigative Site
city: Bobigny Cedex
country: France
facility: Novartis Investigative Site
city: Bois Guillaume
country: France
facility: Novartis Investigative Site
city: Bordeaux Cedex
country: France
facility: Novartis Investigative Site
city: Caen Cedex9
country: France
facility: Novartis Investigative Site
city: Compiegne
country: France
facility: Novartis Investigative Site
city: Lille
country: France
facility: Novartis Investigative Site
city: Marseille
country: France
facility: Novartis Investigative Site
city: Montauban
country: France
facility: Novartis Investigative Site
city: Montpellier 5
country: France
facility: Novartis Investigative Site
city: Nantes Cedex 1
country: France
facility: Novartis Investigative Site
city: Nice
country: France
facility: Novartis Investigative Site
city: Orleans
country: France
facility: Novartis Investigative Site
city: Paris
country: France
facility: Novartis Investigative Site
city: Paris
country: France
facility: Novartis Investigative Site
city: Paris
country: France
facility: Novartis Investigative Site
city: Paris
country: France
facility: Novartis Investigative Site
city: Poitiers
country: France
facility: Novartis Investigative Site
city: Rouen
country: France
facility: Novartis Investigative Site
city: Strasbourg Cedex
country: France
facility: Novartis Investigative Site
city: Tourcoing
country: France
facility: Novartis Investigative Site
city: Valenciennes
country: France
facility: Novartis Investigative Site
city: Vandoeuvre Les Nancy
country: France
facility: Novartis Investigative Site
city: Athens
country: Greece
facility: Novartis Investigative Site
state: GR
city: Ioannina
country: Greece
facility: Novartis Investigative Site
state: GR
city: Thessaloniki
country: Greece
facility: Novartis Investigative Site
state: GR
city: Athens
country: Greece
facility: Novartis Investigative Site
city: Athens
country: Greece
facility: Novartis Investigative Site
city: Athens
country: Greece
facility: Novartis Investigative Site
city: Heraklion Crete
country: Greece
facility: Novartis Investigative Site
city: Thessaloniki
country: Greece
facility: Novartis Investigative Site
city: Thessaloniki
country: Greece
facility: Novartis Investigative Site
city: Hong Kong SAR
country: Hong Kong
facility: Novartis Investigative Site
city: Kowloon
country: Hong Kong
facility: Novartis Investigative Site
city: Pokfulam
country: Hong Kong
facility: Novartis Investigative Site
city: Shatin
country: Hong Kong
facility: Novartis Investigative Site
city: Budapest
country: Hungary
facility: Novartis Investigative Site
state: Pest
city: Zalaegerszeg
country: Hungary
facility: Novartis Investigative Site
state: Zala
city: Balatonfured
country: Hungary
facility: Novartis Investigative Site
city: Budapest
country: Hungary
facility: Novartis Investigative Site
city: Budapest
country: Hungary
facility: Novartis Investigative Site
city: Budapest
country: Hungary
facility: Novartis Investigative Site
city: Budapest
country: Hungary
facility: Novartis Investigative Site
city: Budapest
country: Hungary
facility: Novartis Investigative Site
city: Budapest
country: Hungary
facility: Novartis Investigative Site
city: Debrecen
country: Hungary
facility: Novartis Investigative Site
city: Hatvan
country: Hungary
facility: Novartis Investigative Site
city: Hosszuheteny
country: Hungary
facility: Novartis Investigative Site
city: Mosanmagyarovar
country: Hungary
facility: Novartis Investigative Site
city: Nyiregyhaza
country: Hungary
facility: Novartis Investigative Site
city: Pecs
country: Hungary
facility: Novartis Investigative Site
city: Szeged
country: Hungary
facility: Novartis Investigative Site
city: Szekszard
country: Hungary
facility: Novartis Investigative Site
city: Zalaegerszeg
country: Hungary
facility: Novartis Investigative Site
city: Guntur
country: India
facility: Novartis Investigative Site
state: Andhrapradesh
city: New Delhi
country: India
facility: Novartis Investigative Site
state: Delhi
city: New Delhi
country: India
facility: Novartis Investigative Site
state: Delhi
city: Ahmedabad
country: India
facility: Novartis Investigative Site
state: Gujarat
city: Ahmedabad
country: India
facility: Novartis Investigative Site
state: Gujarat
city: Bangalore
country: India
facility: Novartis Investigative Site
state: Karnataka
city: Bengaluru
country: India
facility: Novartis Investigative Site
state: Karnataka
city: Mangalore
country: India
facility: Novartis Investigative Site
state: Karnataka
city: Manipal
country: India
facility: Novartis Investigative Site
state: Karnataka
city: Mysore
country: India
facility: Novartis Investigative Site
state: Karnataka
city: Kochi
country: India
facility: Novartis Investigative Site
state: Kerala
city: Kochi
country: India
facility: Novartis Investigative Site
state: Kerala
city: Mumbai
country: India
facility: Novartis Investigative Site
state: Maharashtra
city: Nagpur
country: India
facility: Novartis Investigative Site
state: Maharashtra
city: Nagpur
country: India
facility: Novartis Investigative Site
state: Maharashtra
city: Nashik
country: India
facility: Novartis Investigative Site
state: Maharashtra
city: Pune
country: India
facility: Novartis Investigative Site
state: Maharashtra
city: Pune
country: India
facility: Novartis Investigative Site
state: Maharashtra
city: Ajmer
country: India
facility: Novartis Investigative Site
state: Rajasthan
city: Bikaner
country: India
facility: Novartis Investigative Site
state: Rajasthan
city: Jaipur
country: India
facility: Novartis Investigative Site
state: Rajasthan
city: Jaipur
country: India
facility: Novartis Investigative Site
state: Rajasthan
city: Chennai
country: India
facility: Novartis Investigative Site
state: Tamil Nadu
city: Chennai
country: India
facility: Novartis Investigative Site
state: Tamil Nadu
city: Coimbatore
country: India
facility: Novartis Investigative Site
state: Tamil Nadu
city: Madurai
country: India
facility: Novartis Investigative Site
state: Tamil Nadu
city: Kanpur
country: India
facility: Novartis Investigative Site
state: Uttar Pradesh
city: Lucknow
country: India
facility: Novartis Investigative Site
state: Uttar Pradesh
city: Dehradun
country: India
facility: Novartis Investigative Site
state: Uttarakhand
city: Rudrapur
country: India
facility: Novartis Investigative Site
state: Uttarakhand
city: Dehradun
country: India
facility: Novartis Investigative Site
state: Uttrakhand
city: Kolkata
country: India
facility: Novartis Investigative Site
state: West Bengal
city: Belgavi
country: India
facility: Novartis Investigative Site
city: Coimbatore
country: India
facility: Novartis Investigative Site
city: Coimbatore
country: India
facility: Novartis Investigative Site
city: New Delhi
country: India
facility: Novartis Investigative Site
city: Holon
country: Israel
facility: Novartis Investigative Site
state: Gush Dan
city: Beer Sheva
country: Israel
facility: Novartis Investigative Site
city: Haifa
country: Israel
facility: Novartis Investigative Site
city: Jerusalem
country: Israel
facility: Novartis Investigative Site
city: Nahariya
country: Israel
facility: Novartis Investigative Site
city: Petach Tikva
country: Israel
facility: Novartis Investigative Site
city: Poriya
country: Israel
facility: Novartis Investigative Site
city: Ramat Gan
country: Israel
facility: Novartis Investigative Site
city: Rehovot
country: Israel
facility: Novartis Investigative Site
city: Sefad
country: Israel
facility: Novartis Investigative Site
city: Tel Aviv
country: Israel
facility: Novartis Investigative Site
city: Ancona
country: Italy
facility: Novartis Investigative Site
state: AN
city: Brescia
country: Italy
facility: Novartis Investigative Site
state: BS
city: Caserta
country: Italy
facility: Novartis Investigative Site
state: CE
city: Chieti
country: Italy
facility: Novartis Investigative Site
state: CH
city: Firenze
country: Italy
facility: Novartis Investigative Site
state: FI
city: Chiavari
country: Italy
facility: Novartis Investigative Site
state: GE
city: Genova
country: Italy
facility: Novartis Investigative Site
state: GE
city: Pozzilli
country: Italy
facility: Novartis Investigative Site
state: IS
city: Monza
country: Italy
facility: Novartis Investigative Site
state: MB
city: Messina
country: Italy
facility: Novartis Investigative Site
state: ME
city: Cinisello Balsamo
country: Italy
facility: Novartis Investigative Site
state: MI
city: Milano
country: Italy
facility: Novartis Investigative Site
state: MI
city: Milano
country: Italy
facility: Novartis Investigative Site
state: MI
city: Milano
country: Italy
facility: Novartis Investigative Site
state: MI
city: Milano
country: Italy
facility: Novartis Investigative Site
state: MI
city: Milano
country: Italy
facility: Novartis Investigative Site
state: MI
city: Milano
country: Italy
facility: Novartis Investigative Site
state: MI
city: Modena
country: Italy
facility: Novartis Investigative Site
state: MO
city: Perugia
country: Italy
facility: Novartis Investigative Site
state: PG
city: Pisa
country: Italy
facility: Novartis Investigative Site
state: PI
city: Roma
country: Italy
facility: Novartis Investigative Site
state: RM
city: Roma
country: Italy
facility: Novartis Investigative Site
state: RM
city: Siena
country: Italy
facility: Novartis Investigative Site
state: SI
city: Catanzaro
country: Italy
facility: Novartis Investigative Site
city: Latina
country: Italy
facility: Novartis Investigative Site
city: Napoli
country: Italy
facility: Novartis Investigative Site
city: Napoli
country: Italy
facility: Novartis Investigative Site
city: Liepaja
country: Latvia
facility: Novartis Investigative Site
state: LV
city: Ogre
country: Latvia
facility: Novartis Investigative Site
state: LV
city: Daugavpils
country: Latvia
facility: Novartis Investigative Site
city: Kuldiga
country: Latvia
facility: Novartis Investigative Site
city: Riga
country: Latvia
facility: Novartis Investigative Site
city: Riga
country: Latvia
facility: Novartis Investigative Site
city: Riga
country: Latvia
facility: Novartis Investigative Site
city: Kaunas
country: Lithuania
facility: Novartis Investigative Site
state: Kauno Apskritis
city: Kaunas
country: Lithuania
facility: Novartis Investigative Site
state: Kauno Apskritis
city: Klaipeda
country: Lithuania
facility: Novartis Investigative Site
state: Klaipedos Apskritis
city: Klaipeda
country: Lithuania
facility: Novartis Investigative Site
state: Klaipedos Apskritis
city: Alytus
country: Lithuania
facility: Novartis Investigative Site
city: Kaunas
country: Lithuania
facility: Novartis Investigative Site
city: Kaunas
country: Lithuania
facility: Novartis Investigative Site
city: Panevezys
country: Lithuania
facility: Novartis Investigative Site
city: Siauliai
country: Lithuania
facility: Novartis Investigative Site
city: Vilnius
country: Lithuania
facility: Novartis Investigative Site
city: Alor Setar
country: Malaysia
facility: Novartis Investigative Site
state: Kedah
city: Kota Bahru
country: Malaysia
facility: Novartis Investigative Site
state: Kelantan
city: Seremban
country: Malaysia
facility: Novartis Investigative Site
state: Negeri Sembilan
city: Ipoh
country: Malaysia
facility: Novartis Investigative Site
state: Perak
city: Seri Manjung
country: Malaysia
facility: Novartis Investigative Site
state: Perak
city: Taiping
country: Malaysia
facility: Novartis Investigative Site
state: Perak
city: Timur Laut
country: Malaysia
facility: Novartis Investigative Site
state: Pulau Pinang
city: Kuching
country: Malaysia
facility: Novartis Investigative Site
state: Sarawak
city: Miri
country: Malaysia
facility: Novartis Investigative Site
state: Sarawak
city: Sungai Buloh
country: Malaysia
facility: Novartis Investigative Site
state: Selangor Darul Ehsan
city: Kuala Lumpur
country: Malaysia
facility: Novartis Investigative Site
state: Wilayah Persekutuan
city: Johor Bahru
country: Malaysia
facility: Novartis Investigative Site
city: Kuala Lumpur
country: Malaysia
facility: Novartis Investigative Site
city: Cuauhtemoc
country: Mexico
facility: Novartis Investigative Site
state: Cdmx
city: Gustavo A Madero
country: Mexico
facility: Novartis Investigative Site
state: Ciudad De Mexico
city: Ciudad de Mexico
country: Mexico
facility: Novartis Investigative Site
state: Distrito Federal
city: Mexico
country: Mexico
facility: Novartis Investigative Site
state: Distrito Federal
city: Leon
country: Mexico
facility: Novartis Investigative Site
state: Guanajuato
city: Actopan
country: Mexico
facility: Novartis Investigative Site
state: Hidalgo
city: Guadalajara
country: Mexico
facility: Novartis Investigative Site
state: Jalisco
city: Guadalajara
country: Mexico
facility: Novartis Investigative Site
state: Jalisco
city: Guadalajara
country: Mexico
facility: Novartis Investigative Site
state: Jalisco
city: Cuernavaca
country: Mexico
facility: Novartis Investigative Site
state: Morelos
city: Monterrey
country: Mexico
facility: Novartis Investigative Site
state: Nuevo Leon
city: Monterrey
country: Mexico
facility: Novartis Investigative Site
state: Nuevo Leon
city: Monterrey
country: Mexico
facility: Novartis Investigative Site
state: Nuevo Leon
city: Monterrey
country: Mexico
facility: Novartis Investigative Site
state: Nuevo Leon
city: Culiacan
country: Mexico
facility: Novartis Investigative Site
state: Sinaloa
city: Culiacan
country: Mexico
facility: Novartis Investigative Site
state: Sinaloa
city: Tampico
country: Mexico
facility: Novartis Investigative Site
state: Tamaulipas
city: Merida
country: Mexico
facility: Novartis Investigative Site
state: Yucatan
city: Aguascalientes
country: Mexico
facility: Novartis Investigative Site
city: Aguascalientes
country: Mexico
facility: Novartis Investigative Site
city: Chihuahua
country: Mexico
facility: Novartis Investigative Site
city: Distrito Federal
country: Mexico
facility: Novartis Investigative Site
city: Distrito Federal
country: Mexico
facility: Novartis Investigative Site
city: Mexico D F
country: Mexico
facility: Novartis Investigative Site
city: Oaxaca
country: Mexico
facility: Novartis Investigative Site
city: San Luis Potosi
country: Mexico
facility: Novartis Investigative Site
city: Veracruz
country: Mexico
facility: Novartis Investigative Site
city: Arnhem
country: Netherlands
facility: Novartis Investigative Site
state: Gelderland
city: Doetinchem
country: Netherlands
facility: Novartis Investigative Site
state: Gelderland
city: Amsterdam
country: Netherlands
facility: Novartis Investigative Site
city: Amsterdam
country: Netherlands
facility: Novartis Investigative Site
city: Beverwijk
country: Netherlands
facility: Novartis Investigative Site
city: Delft
country: Netherlands
facility: Novartis Investigative Site
city: Den Bosch
country: Netherlands
facility: Novartis Investigative Site
city: Den Haag
country: Netherlands
facility: Novartis Investigative Site
city: Deventer
country: Netherlands
facility: Novartis Investigative Site
city: Dirksland
country: Netherlands
facility: Novartis Investigative Site
city: Dordrecht
country: Netherlands
facility: Novartis Investigative Site
city: Ede
country: Netherlands
facility: Novartis Investigative Site
city: Eindhoven
country: Netherlands
facility: Novartis Investigative Site
city: Enschede
country: Netherlands
facility: Novartis Investigative Site
city: Gouda
country: Netherlands
facility: Novartis Investigative Site
city: Hardenberg
country: Netherlands
facility: Novartis Investigative Site
city: Leeuwarden
country: Netherlands
facility: Novartis Investigative Site
city: Nijmegen
country: Netherlands
facility: Novartis Investigative Site
city: Nijmegen
country: Netherlands
facility: Novartis Investigative Site
city: Sneek
country: Netherlands
facility: Novartis Investigative Site
city: Tilburg
country: Netherlands
facility: Novartis Investigative Site
city: Venlo
country: Netherlands
facility: Novartis Investigative Site
city: Manila
country: Philippines
facility: Novartis Investigative Site
state: Metro Manila
city: Iloilo
country: Philippines
facility: Novartis Investigative Site
city: Manila
country: Philippines
facility: Novartis Investigative Site
city: Quezon
country: Philippines
facility: Novartis Investigative Site
city: San Juan City
country: Philippines
facility: Novartis Investigative Site
city: Tarnow
country: Poland
facility: Novartis Investigative Site
state: Malopolskie
city: Krakow
country: Poland
facility: Novartis Investigative Site
state: Maloposkie
city: Bialystok
country: Poland
facility: Novartis Investigative Site
city: Bydgoszcz
country: Poland
facility: Novartis Investigative Site
city: Bydgoszcz
country: Poland
facility: Novartis Investigative Site
city: Bygdoszcz
country: Poland
facility: Novartis Investigative Site
city: Chorzow
country: Poland
facility: Novartis Investigative Site
city: Elblag
country: Poland
facility: Novartis Investigative Site
city: Gdynia
country: Poland
facility: Novartis Investigative Site
city: Golub-Dobrzyn
country: Poland
facility: Novartis Investigative Site
city: Grudziadz
country: Poland
facility: Novartis Investigative Site
city: Katowice
country: Poland
facility: Novartis Investigative Site
city: Katowice
country: Poland
facility: Novartis Investigative Site
city: Katowice
country: Poland
facility: Novartis Investigative Site
city: Krakow
country: Poland
facility: Novartis Investigative Site
city: Krakow
country: Poland
facility: Novartis Investigative Site
city: Krakow
country: Poland
facility: Novartis Investigative Site
city: Lodz
country: Poland
facility: Novartis Investigative Site
city: Lodz
country: Poland
facility: Novartis Investigative Site
city: Myszkow
country: Poland
facility: Novartis Investigative Site
city: Olsztyn
country: Poland
facility: Novartis Investigative Site
city: Piotrkow Trybunalski
country: Poland
facility: Novartis Investigative Site
city: Rzeszow
country: Poland
facility: Novartis Investigative Site
city: Warszawa
country: Poland
facility: Novartis Investigative Site
city: Wroclaw
country: Poland
facility: Novartis Investigative Site
city: Wroclaw
country: Poland
facility: Novartis Investigative Site
city: Carnaxide
country: Portugal
facility: Novartis Investigative Site
state: Lisboa
city: Almada
country: Portugal
facility: Novartis Investigative Site
city: Coimbra
country: Portugal
facility: Novartis Investigative Site
city: Lisboa
country: Portugal
facility: Novartis Investigative Site
city: Lisboa
country: Portugal
facility: Novartis Investigative Site
city: Matosinhos
country: Portugal
facility: Novartis Investigative Site
city: Porto
country: Portugal
facility: Novartis Investigative Site
city: Santa Maria da Feira
country: Portugal
facility: Novartis Investigative Site
city: Setubal
country: Portugal
facility: Novartis Investigative Site
city: Vila Nova De Gaia
country: Portugal
facility: Novartis Investigative Site
city: Ponce
country: Puerto Rico
facility: Research and Cardiovascular Corp
city: Pitesti
country: Romania
facility: Novartis Investigative Site
state: Arges
city: Oradea
country: Romania
facility: Novartis Investigative Site
state: Bihor
city: Afumati
country: Romania
facility: Novartis Investigative Site
state: Ilfov
city: Craiova
country: Romania
facility: Novartis Investigative Site
state: Jud Dolj
city: Targu Mures
country: Romania
facility: Novartis Investigative Site
state: Mures
city: Targu Mures
country: Romania
facility: Novartis Investigative Site
state: Mures
city: Timisoara
country: Romania
facility: Novartis Investigative Site
state: Timis
city: Timisoara
country: Romania
facility: Novartis Investigative Site
state: Timis
city: Timisoara
country: Romania
facility: Novartis Investigative Site
state: Timis
city: Timisoara
country: Romania
facility: Novartis Investigative Site
state: Timis
city: Baia Mare
country: Romania
facility: Novartis Investigative Site
city: Baia Mare
country: Romania
facility: Novartis Investigative Site
city: Braila
country: Romania
facility: Novartis Investigative Site
city: Brasov
country: Romania
facility: Novartis Investigative Site
city: Bucharest
country: Romania
facility: Novartis Investigative Site
city: Bucharest
country: Romania
facility: Novartis Investigative Site
city: Bucharest
country: Romania
facility: Novartis Investigative Site
city: Bucharest
country: Romania
facility: Novartis Investigative Site
city: Bucharest
country: Romania
facility: Novartis Investigative Site
city: Bucharest
country: Romania
facility: Novartis Investigative Site
city: Bucuresti
country: Romania
facility: Novartis Investigative Site
city: Bucuresti
country: Romania
facility: Novartis Investigative Site
city: Buzau
country: Romania
facility: Novartis Investigative Site
city: Cluj Napoca
country: Romania
facility: Novartis Investigative Site
city: Cluj Napoca
country: Romania
facility: Novartis Investigative Site
city: Cluj-Napoca
country: Romania
facility: Novartis Investigative Site
city: Craiova
country: Romania
facility: Novartis Investigative Site
city: Lasi
country: Romania
facility: Novartis Investigative Site
city: Suceava
country: Romania
facility: Novartis Investigative Site
city: Targu Mures
country: Romania
facility: Novartis Investigative Site
city: Targu Mures
country: Romania
facility: Novartis Investigative Site
city: Timisoara
country: Romania
facility: Novartis Investigative Site
city: Tirgoviste
country: Romania
facility: Novartis Investigative Site
city: Singapore
country: Singapore
facility: Novartis Investigative Site
city: Singapore
country: Singapore
facility: Novartis Investigative Site
city: Singapore
country: Singapore
facility: Novartis Investigative Site
city: Singapore
country: Singapore
facility: Novartis Investigative Site
city: Lucenec
country: Slovakia
facility: Novartis Investigative Site
state: Slovak Republic
city: Nitra
country: Slovakia
facility: Novartis Investigative Site
state: Slovak Republic
city: Bardejov
country: Slovakia
facility: Novartis Investigative Site
city: Bardejov
country: Slovakia
facility: Novartis Investigative Site
city: Bratislava
country: Slovakia
facility: Novartis Investigative Site
city: Bratislava
country: Slovakia
facility: Novartis Investigative Site
city: Bratislava
country: Slovakia
facility: Novartis Investigative Site
city: Bratislava
country: Slovakia
facility: Novartis Investigative Site
city: Bratislava
country: Slovakia
facility: Novartis Investigative Site
city: Bratislava
country: Slovakia
facility: Novartis Investigative Site
city: Bratislava
country: Slovakia
facility: Novartis Investigative Site
city: Bratislava
country: Slovakia
facility: Novartis Investigative Site
city: Bratislava
country: Slovakia
facility: Novartis Investigative Site
city: Dolny Kubin
country: Slovakia
facility: Novartis Investigative Site
city: Kosice
country: Slovakia
facility: Novartis Investigative Site
city: Kosice
country: Slovakia
facility: Novartis Investigative Site
city: Kralovsky Chlmec
country: Slovakia
facility: Novartis Investigative Site
city: Lubochna
country: Slovakia
facility: Novartis Investigative Site
city: Lucenec
country: Slovakia
facility: Novartis Investigative Site
city: Malacky
country: Slovakia
facility: Novartis Investigative Site
city: Nitra
country: Slovakia
facility: Novartis Investigative Site
city: Nitra
country: Slovakia
facility: Novartis Investigative Site
city: Nove Zamky
country: Slovakia
facility: Novartis Investigative Site
city: Presov
country: Slovakia
facility: Novartis Investigative Site
city: Presov
country: Slovakia
facility: Novartis Investigative Site
city: Roznava
country: Slovakia
facility: Novartis Investigative Site
city: Samorin
country: Slovakia
facility: Novartis Investigative Site
city: Svidnik
country: Slovakia
facility: Novartis Investigative Site
city: Trnava
country: Slovakia
facility: Novartis Investigative Site
city: Port Elizabeth
country: South Africa
facility: Novartis Investigative Site
state: Eastern Cape
city: Bloemfontein
country: South Africa
facility: Novartis Investigative Site
state: Free State
city: Pretoria
country: South Africa
facility: Novartis Investigative Site
state: Gauteng
city: Kwadukuza
country: South Africa
facility: Novartis Investigative Site
state: Kwazulu Natal
city: Bellville
country: South Africa
facility: Novartis Investigative Site
state: Western Cape
city: Cape Town
country: South Africa
facility: Novartis Investigative Site
state: Western Cape
city: George
country: South Africa
facility: Novartis Investigative Site
state: Western Cape
city: Somerset West
country: South Africa
facility: Novartis Investigative Site
state: Western Cape
city: Cape Town
country: South Africa
facility: Novartis Investigative Site
state: ZAF
city: Cape Town
country: South Africa
facility: Novartis Investigative Site
city: Western Cape
country: South Africa
facility: Novartis Investigative Site
city: Santiago de Compostela
country: Spain
facility: Novartis Investigative Site
state: A Coruna
city: Elche
country: Spain
facility: Novartis Investigative Site
state: Alicante
city: Almeria
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Cordoba
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Granada
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Huelva
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Malaga
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Malaga
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Marbella
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Sanlucar de Barrameda
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Sevilla
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Sevilla
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Utrera
country: Spain
facility: Novartis Investigative Site
state: Andalucia
city: Palma
country: Spain
facility: Novartis Investigative Site
state: Balears
city: Centelles
country: Spain
facility: Novartis Investigative Site
state: Barcelona
city: El Prat de Llobregat
country: Spain
facility: Novartis Investigative Site
state: Barcelona
city: La Roca del Valles
country: Spain
facility: Novartis Investigative Site
state: Barcelona
city: Mataro
country: Spain
facility: Novartis Investigative Site
state: Barcelona
city: Sant Adria Del Besos
country: Spain
facility: Novartis Investigative Site
state: Barcelona
city: Vic
country: Spain
facility: Novartis Investigative Site
state: Barcelona
city: Puerto Real
country: Spain
facility: Novartis Investigative Site
state: Cadiz
city: Villamartin
country: Spain
facility: Novartis Investigative Site
state: Cadiz
city: Santander
country: Spain
facility: Novartis Investigative Site
state: Cantabria
city: Salamanca
country: Spain
facility: Novartis Investigative Site
state: Castilla Y Leon
city: Barcelona
country: Spain
facility: Novartis Investigative Site
state: Cataluna
city: Barcelona
country: Spain
facility: Novartis Investigative Site
state: Cataluna
city: Reus
country: Spain
facility: Novartis Investigative Site
state: Cataluna
city: Badalona
country: Spain
facility: Novartis Investigative Site
state: Catalunya
city: Barcelona
country: Spain
facility: Novartis Investigative Site
state: Catalunya
city: Barcelona
country: Spain
facility: Novartis Investigative Site
state: Catalunya
city: Alzira
country: Spain
facility: Novartis Investigative Site
state: Comunidad Valenciana
city: Valencia
country: Spain
facility: Novartis Investigative Site
state: Comunidad Valenciana
city: Caceres
country: Spain
facility: Novartis Investigative Site
state: Extremadura
city: A Coruna
country: Spain
facility: Novartis Investigative Site
state: Galicia
city: La Coruna
country: Spain
facility: Novartis Investigative Site
state: Galicia
city: Santiago De Compostela
country: Spain
facility: Novartis Investigative Site
state: Galicia
city: Peralada
country: Spain
facility: Novartis Investigative Site
state: Girona
city: Mallorca
country: Spain
facility: Novartis Investigative Site
state: Islas Baleares
city: Boadilla del Monte
country: Spain
facility: Novartis Investigative Site
state: Madrid
city: Fuenlabrada
country: Spain
facility: Novartis Investigative Site
state: Madrid
city: Pozuelo de Alarcon
country: Spain
facility: Novartis Investigative Site
state: Madrid
city: Antequera
country: Spain
facility: Novartis Investigative Site
state: Malaga
city: Ronda
country: Spain
facility: Novartis Investigative Site
state: Malaga
city: El Palmar
country: Spain
facility: Novartis Investigative Site
state: Murcia
city: Pamplona
country: Spain
facility: Novartis Investigative Site
state: Navarra
city: La Laguna
country: Spain
facility: Novartis Investigative Site
state: Santa Cruz De Tenerife
city: Castilleja De La Cuesta
country: Spain
facility: Novartis Investigative Site
state: Sevilla
city: Lebrija
country: Spain
facility: Novartis Investigative Site
state: Sevilla
city: A Coruna
country: Spain
facility: Novartis Investigative Site
city: Alicante
country: Spain
facility: Novartis Investigative Site
city: Barcelona
country: Spain
facility: Novartis Investigative Site
city: Barcelona
country: Spain
facility: Novartis Investigative Site
city: Barcelona
country: Spain
facility: Novartis Investigative Site
city: Ferrol
country: Spain
facility: Novartis Investigative Site
city: Huelva
country: Spain
facility: Novartis Investigative Site
city: Las Palmas de Gran Canaria
country: Spain
facility: Novartis Investigative Site
city: Las Palmas de Gran Canaria
country: Spain
facility: Novartis Investigative Site
city: Madrid
country: Spain
facility: Novartis Investigative Site
city: Madrid
country: Spain
facility: Novartis Investigative Site
city: Madrid
country: Spain
facility: Novartis Investigative Site
city: Madrid
country: Spain
facility: Novartis Investigative Site
city: Madrid
country: Spain
facility: Novartis Investigative Site
city: Madrid
country: Spain
facility: Novartis Investigative Site
city: Tarragona
country: Spain
facility: Novartis Investigative Site
city: Zaragoza
country: Spain
facility: Novartis Investigative Site
city: Malmo
country: Sweden
facility: Novartis Investigative Site
state: Skane Lan
city: Goteborg
country: Sweden
facility: Novartis Investigative Site
city: Linkoping
country: Sweden
facility: Novartis Investigative Site
city: Lund
country: Sweden
facility: Novartis Investigative Site
city: Solna
country: Sweden
facility: Novartis Investigative Site
city: Stockholm
country: Sweden
facility: Novartis Investigative Site
city: Uppsala
country: Sweden
facility: Novartis Investigative Site
city: Vasteras
country: Sweden
facility: Novartis Investigative Site
city: Basel
country: Switzerland
facility: Novartis Investigative Site
city: Bern
country: Switzerland
facility: Novartis Investigative Site
city: Geneve 14
country: Switzerland
facility: Novartis Investigative Site
city: Lugano
country: Switzerland
facility: Novartis Investigative Site
city: Luzern 16
country: Switzerland
facility: Novartis Investigative Site
city: Taichung
country: Taiwan
facility: Novartis Investigative Site
state: Taiwan ROC
city: Changhua
country: Taiwan
facility: Novartis Investigative Site
city: Kaohsiung
country: Taiwan
facility: Novartis Investigative Site
city: Taichung
country: Taiwan
facility: Novartis Investigative Site
city: Tainan
country: Taiwan
facility: Novartis Investigative Site
city: Tainan
country: Taiwan
facility: Novartis Investigative Site
city: Taipei
country: Taiwan
facility: Novartis Investigative Site
city: Taipei
country: Taiwan
facility: Novartis Investigative Site
city: Taoyuan
country: Taiwan
facility: Novartis Investigative Site
city: Songkhla
country: Thailand
facility: Novartis Investigative Site
state: Hat Yai
city: Khon Kaen
country: Thailand
facility: Novartis Investigative Site
state: THA
city: Bangkok
country: Thailand
facility: Novartis Investigative Site
city: Bangkok
country: Thailand
facility: Novartis Investigative Site
city: Bangkok
country: Thailand
facility: Novartis Investigative Site
city: Chiang Mai
country: Thailand
facility: Novartis Investigative Site
city: Muang
country: Thailand
facility: Novartis Investigative Site
city: Izmir
country: Turkey
facility: Novartis Investigative Site
state: Bayrakli
city: Meselik
country: Turkey
facility: Novartis Investigative Site
state: Eskisehir
city: Ankara
country: Turkey
facility: Novartis Investigative Site
city: Ankara
country: Turkey
facility: Novartis Investigative Site
city: Denizli
country: Turkey
facility: Novartis Investigative Site
city: Gaziantep
country: Turkey
facility: Novartis Investigative Site
city: Haydarpasa Istanbul
country: Turkey
facility: Novartis Investigative Site
city: Istanbul
country: Turkey
facility: Novartis Investigative Site
city: Istanbul
country: Turkey
facility: Novartis Investigative Site
city: Izmir
country: Turkey
facility: Novartis Investigative Site
city: Izmir
country: Turkey
facility: Novartis Investigative Site
city: Kucukcekmece Istanbul
country: Turkey
facility: Novartis Investigative Site
city: Mersin
country: Turkey
facility: Novartis Investigative Site
city: Mugla
country: Turkey
facility: Novartis Investigative Site
city: Talas Kayseri
country: Turkey
facility: Novartis Investigative Site
city: Luton
country: United Kingdom
facility: Novartis Investigative Site
state: Beds
city: High Wycombe
country: United Kingdom
facility: Novartis Investigative Site
state: Buckinghamshire
city: Peterborough
country: United Kingdom
facility: Novartis Investigative Site
state: Cambridgeshire
city: Connor Downs
country: United Kingdom
facility: Novartis Investigative Site
state: Cornwall
city: Fowey
country: United Kingdom
facility: Novartis Investigative Site
state: Cornwall
city: Liskeard
country: United Kingdom
facility: Novartis Investigative Site
state: Cornwall
city: Newquay
country: United Kingdom
facility: Novartis Investigative Site
state: Cornwall
city: Exeter
country: United Kingdom
facility: Novartis Investigative Site
state: Devon
city: Dorchester
country: United Kingdom
facility: Novartis Investigative Site
state: Dorset
city: London
country: United Kingdom
facility: Novartis Investigative Site
state: GBR
city: Harrow
country: United Kingdom
facility: Novartis Investigative Site
state: Middlesex
city: Corby
country: United Kingdom
facility: Novartis Investigative Site
state: Northamptonshire
city: Portadown
country: United Kingdom
facility: Novartis Investigative Site
state: Nothern Ireland
city: Wansford
country: United Kingdom
facility: Novartis Investigative Site
state: Peterborough
city: Bristol
country: United Kingdom
facility: Novartis Investigative Site
state: South Gloucestershire
city: Hardwick
country: United Kingdom
facility: Novartis Investigative Site
state: Stockton On Tees
city: Bury St Edmunds
country: United Kingdom
facility: Novartis Investigative Site
state: Suffolk
city: Cardiff
country: United Kingdom
facility: Novartis Investigative Site
state: Wales
city: Cardiff
country: United Kingdom
facility: Novartis Investigative Site
state: Wales
city: Belfast
country: United Kingdom
facility: Novartis Investigative Site
city: Belfast
country: United Kingdom
facility: Novartis Investigative Site
city: Birmingham
country: United Kingdom
facility: Novartis Investigative Site
city: Blackpool
country: United Kingdom
facility: Novartis Investigative Site
city: Bristol
country: United Kingdom
facility: Novartis Investigative Site
city: Cardiff
country: United Kingdom
facility: Novartis Investigative Site
city: Chesterfield
country: United Kingdom
facility: Novartis Investigative Site
city: Denbighshire
country: United Kingdom
facility: Novartis Investigative Site
city: Edinburgh
country: United Kingdom
facility: Novartis Investigative Site
city: Glasgow
country: United Kingdom
facility: Novartis Investigative Site
city: Kettering
country: United Kingdom
facility: Novartis Investigative Site
city: Lancashire
country: United Kingdom
facility: Novartis Investigative Site
city: Londonderry
country: United Kingdom
facility: Novartis Investigative Site
city: London
country: United Kingdom
facility: Novartis Investigative Site
city: Middlesex
country: United Kingdom
facility: Novartis Investigative Site
city: Norwich
country: United Kingdom
facility: Novartis Investigative Site
city: Plymouth
country: United Kingdom
facility: Novartis Investigative Site
city: Plympton
country: United Kingdom
facility: Novartis Investigative Site
city: Rhyl
country: United Kingdom
facility: Novartis Investigative Site
city: Salford
country: United Kingdom
facility: Novartis Investigative Site
city: Scunthorpe
country: United Kingdom
facility: Novartis Investigative Site
city: Sheffield
country: United Kingdom
facility: Novartis Investigative Site
city: Tyne And Wear
country: United Kingdom
facility: Novartis Investigative Site
city: Wiltshire
country: United Kingdom
facility: Novartis Investigative Site
city: Wirrel
country: United Kingdom
facility: Novartis Investigative Site
city: Wrexham
country: United Kingdom
facility: Novartis Investigative Site
city: Hanoi
country: Vietnam
facility: Novartis Investigative Site
city: Ho Chi Minh
country: Vietnam
facility: Novartis Investigative Site
Study officials:
affiliation: Novartis Pharmaceuticals
name: Novartis Pharmaceuticals
role: STUDY_DIRECTOR
References: